Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

Moise-Broder, Pamela A; Sakoulas, George; Eliopoulos, George M; Schentag, Jerome J; Forrest, Alan; Moellering, Robert C

Moise-Broder, Pamela A; Sakoulas, George; Eliopoulos, George M; Schentag, Jerome J; Forrest, Alan; Moellering, Robert C.

Affiliation

Moise-Broder PA; School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, USA. pmoise@cplassociates.com

Clin Infect Dis ; 38(12): 1700-5, 2004 Jun 15.

Article in En | MEDLINE | ID: mdl-15227615

Subject(s)

Bacterial Proteins/genetics; Methicillin Resistance/genetics; Polymorphism, Genetic; Staphylococcus aureus/genetics; Trans-Activators/genetics; Vancomycin Resistance/genetics; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Staphylococcal Infections/drug therapy; Staphylococcal Infections/microbiology; Vancomycin/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Polymorphism, Genetic / Staphylococcus aureus / Bacterial Proteins / Trans-Activators / Methicillin Resistance / Vancomycin Resistance Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Infect Dis Year: 2004 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links